 EMERYVILLE, Calif., Feb. 11, 2022 GLOBE NEWSWIRE -- 4D Molecular Therapeutics, Inc. Nasdaq: FDMT, a clinical-stage gene therapy company harnessing the power of directed evolution for targeted gene therapies, announced that management will participate in the 11th Annual SVB Leerink Global Healthcare Conference on Wednesday, February 16th. Details of the fireside chat are as follows: 